Cassava Sciences, Inc.
(NASDAQ: SAVA)

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

2.055 -

-0.095 (-4.42%)
价格区间 2.045 - 2.170   (6.11%)
开盘 2.150
昨收 2.150
买 2.050
买盘 944
卖 2.060
卖盘 1,454
成交量 260,539
成交额 390,717
注释 -
数据延迟。最后一次更新13 Feb 2026 01:35.
数据提供商
查看所有活动

Loading Chart...

Please login to view stock data and analysis